NEWS

COVID-19 is making the case for accelerating the move to more value-based models of care.  Hospitals’ financial struggles as they pause...

Clinical trial enrollment has dropped massively across the world with endocrine and cardiovascular tests being the hardest hit. This is according...

Pharma marketing, like the rest of the ad industry, is in a state of flux brought on by the COVID-19 pandemic. Concerns and debates are swirling...

It’s a pretty extraordinary story that started off with a CEO exiting a biotech and has now become about the U.S. president allegedly wanting to...

The novel coronavirus has hit home at Biogen, where three executives who traveled to a headquarters management meeting have tested positive for...

Around 10 PM ET last night, the FDA said that it is aware of a drug shortage related to an active pharmaceutical ingredient (API) manufacturer...

Direct-to-consumer drug ads tend to strike a dissonant chord. However, fan and foe can count on one thing: Prescription DTC advertising is here...

After years of opioid litigation and a multibillion-dollar settlement offer from the nation's top drug distributors, nearly two dozen U.S. states...

Drug pricing remains a hot topic, and a new report offers some reasons: The most expensive drugs sold at pharmacies can cost as much as a luxury...

French pharma Servier begins trial today, as the company stands accused of manslaughter and deceit over a diabetes weight loss drug linked to as...

Тhe BACE theory of controlling Alzheimer’s died with failed pivotal projects at Merck, Eli Lilly and their partners at AstraZeneca. Now Amgen and...

When a new drug is approved, the developer usually trumpets its ability to fill an unmet medical need. But a German agency that evaluates...